Fixed Phage
A biotechnology company developing and commercialising unique, proprietary, anti-infective technologies based on bacteriophage immobilisation and stabilisation.
The UK based company is developing a well-proven and comprehensively patented surface modification technology, that irreversibly attaches and stabilises bacteriophages on a wide range of carrier materials, thereby creating biologically active interventions.t is developing a well-proven and comprehensively patented surface modification technology, that irreversibly attaches and stabilises bacteriophages on a wide range
Fixed Phage’s technology can be applied across a number of industries including Food Freshness, Aquaculture as well as Animal and Human Health & Wellbeing.
Latest Fixed Phage News & Features
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze